Tags

Type your tag names separated by a space and hit enter

Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway.
Mediators Inflamm. 2020; 2020:8865647.MI

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder prevalent in females of reproductive age; insulin resistance (IR) is the major pathogenic driver. Pharmacology is a basic option for PCOS therapy; traditional Chinese medicine (TCM), as a significant part of complementary and alternative medicine, has a long history in the clinical management of PCOS. Cangfudaotan decoction (CFD) has been used clinically for gynaecological diseases especially PCOS. In this study, first, chemical components in CFD were clarified using UPLC-Q/TOF-MS analysis. Then, an animal model of PCOS was established, granular cells were also isolated from the rats with PCOS, and CFD was administrated at different dosages in PCOS rats and granular cells, to investigate the therapeutic effect and mechanisms of CFD for PCOS treatment. The result showed that CFD treatment is effective in PCOS rats and granulosa cells. CFD was able to improve IR, restore the serum hormone levels, inhibit the inflammatory cytokines in PCOS rat, and alleviate ovary morphological injury and apoptosis in PCOS rats. In granulosa cells of PCOS, the result showed that the cell viability was improved, and cell apoptosis was inhibited after CFD administration. Further experiments suggested that CDF improves IR, follicular development, cell apoptosis, and inflammatory microenvironment, and this was associated to the regulation of IGF-1-PI3K/Akt-Bax/Bcl-2 pathway-mediated gene expression. Given that CFD sufficiently suppresses insulin resistance and improves follicular development in this study, exploring these mechanisms might help to optimize the therapeutic treatment of CFD in PCOS patients.

Authors+Show Affiliations

Department of Reproductive Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, 310003 Zhejiang, China.Department of Reproductive Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, 310003 Zhejiang, China.Department of Reproductive Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, 310003 Zhejiang, China.Department of Reproductive Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, 310003 Zhejiang, China.Department of Reproductive Medicine, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, 310003 Zhejiang, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33299379

Citation

Wang, Chenye, et al. "Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats With Polycystic Ovary Syndrome Via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway." Mediators of Inflammation, vol. 2020, 2020, p. 8865647.
Wang C, Ding C, Hua Z, et al. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators Inflamm. 2020;2020:8865647.
Wang, C., Ding, C., Hua, Z., Chen, C., & Yu, J. (2020). Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators of Inflammation, 2020, 8865647. https://doi.org/10.1155/2020/8865647
Wang C, et al. Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats With Polycystic Ovary Syndrome Via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators Inflamm. 2020;2020:8865647. PubMed PMID: 33299379.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. AU - Wang,Chenye, AU - Ding,Caifei, AU - Hua,Zhoujia, AU - Chen,Chunyue, AU - Yu,Jia, Y1 - 2020/11/24/ PY - 2020/09/19/received PY - 2020/10/26/revised PY - 2020/11/02/accepted PY - 2020/12/10/entrez PY - 2020/12/11/pubmed PY - 2021/11/4/medline SP - 8865647 EP - 8865647 JF - Mediators of inflammation JO - Mediators Inflamm VL - 2020 N2 - Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder prevalent in females of reproductive age; insulin resistance (IR) is the major pathogenic driver. Pharmacology is a basic option for PCOS therapy; traditional Chinese medicine (TCM), as a significant part of complementary and alternative medicine, has a long history in the clinical management of PCOS. Cangfudaotan decoction (CFD) has been used clinically for gynaecological diseases especially PCOS. In this study, first, chemical components in CFD were clarified using UPLC-Q/TOF-MS analysis. Then, an animal model of PCOS was established, granular cells were also isolated from the rats with PCOS, and CFD was administrated at different dosages in PCOS rats and granular cells, to investigate the therapeutic effect and mechanisms of CFD for PCOS treatment. The result showed that CFD treatment is effective in PCOS rats and granulosa cells. CFD was able to improve IR, restore the serum hormone levels, inhibit the inflammatory cytokines in PCOS rat, and alleviate ovary morphological injury and apoptosis in PCOS rats. In granulosa cells of PCOS, the result showed that the cell viability was improved, and cell apoptosis was inhibited after CFD administration. Further experiments suggested that CDF improves IR, follicular development, cell apoptosis, and inflammatory microenvironment, and this was associated to the regulation of IGF-1-PI3K/Akt-Bax/Bcl-2 pathway-mediated gene expression. Given that CFD sufficiently suppresses insulin resistance and improves follicular development in this study, exploring these mechanisms might help to optimize the therapeutic treatment of CFD in PCOS patients. SN - 1466-1861 UR - https://www.unboundmedicine.com/medline/citation/33299379/Cangfudaotan_Decoction_Alleviates_Insulin_Resistance_and_Improves_Follicular_Development_in_Rats_with_Polycystic_Ovary_Syndrome_via_IGF_1_PI3K/Akt_Bax/Bcl_2_Pathway_ DB - PRIME DP - Unbound Medicine ER -